Dealroom - Healthtech 2022

Healthtech & Biotech was the second most funded startup industry in 2022, according to Dealroom's report. However, funding for the industry fell by 29% from the highs in 2021. The report highlights that AI-drug development and Telemedicine are the top sectors that attracted healthtech venture capital funding. Additionally, the report shows that healthtech funding fell in all major markets in 2022, with the US being the most resilient. The report provides an overview of the healthtech industry and funding trends in 2022, with insights on the sectors and regions that performed well and those that faced challenges. It also highlights the impact of the current global economic and political environment on the industry, and the key trends and opportunities that are expected to shape the industry in the coming years.